“HealthPrize RespiPoints Program Improves Adherence and Persistence to COPD Medications, Reducing Hospitalizations and Medical Costs”

https://pubmed.ncbi.nlm.nih.gov/38116664

The HealthPrize RespiPoints™ program improved medication adherence and persistence in COPD patients using tiotropium or tiotropium/olodaterol, resulting in lower hospitalization rates and slightly reduced total medical costs.